Therapeutic efficacy of


Journal

Chemical science
ISSN: 2041-6520
Titre abrégé: Chem Sci
Pays: England
ID NLM: 101545951

Informations de publication

Date de publication:
02 Aug 2023
Historique:
received: 18 05 2023
accepted: 26 05 2023
medline: 4 8 2023
pubmed: 4 8 2023
entrez: 4 8 2023
Statut: epublish

Résumé

Targeted α-particle therapy (TAT) is an attractive alternative to conventional therapy for cancer treatment. Among the available radionuclides considered for TAT, astatine-211 (

Identifiants

pubmed: 37538829
doi: 10.1039/d3sc02513f
pii: d3sc02513f
pmc: PMC10395307
doi:

Types de publication

Journal Article

Langues

eng

Pagination

8054-8060

Informations de copyright

This journal is © The Royal Society of Chemistry.

Déclaration de conflit d'intérêts

There are no conflicts to declare.

Références

Bioconjug Chem. 1991 May-Jun;2(3):171-9
pubmed: 1932216
Sci Rep. 2011;1:82
pubmed: 22355601
Bioconjug Chem. 1992 Nov-Dec;3(6):499-503
pubmed: 1463779
J Nanobiotechnology. 2021 Jul 28;19(1):223
pubmed: 34320997
Appl Radiat Isot. 1996 Feb;47(2):135-43
pubmed: 8852627
Cancer Biother Radiopharm. 2013 Feb;28(1):1-20
pubmed: 23075373
Hum Toxicol. 1988 Nov;7(6):529-34
pubmed: 3229761
Cancer Biother Radiopharm. 2020 Aug;35(6):425-436
pubmed: 32077749
Appl Radiat Isot. 2006 Oct-Nov;64(10-11):1365-9
pubmed: 16563782
Anal Biochem. 2002 Jun 15;305(2):251-9
pubmed: 12054454
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4882-7
pubmed: 9560197
Cancer Sci. 2017 Aug;108(8):1648-1656
pubmed: 28514062
Crit Rev Toxicol. 2005 Aug;35(7):609-62
pubmed: 16417045
Bioorg Med Chem. 2020 Dec 15;28(24):115831
pubmed: 33199202
Proc Natl Acad Sci U S A. 1940 Aug 15;26(8):483-9
pubmed: 16588388
Bioorg Med Chem. 2019 Jun 1;27(11):2228-2234
pubmed: 31023557
Mol Nutr Food Res. 2008 Jan;52(1):7-25
pubmed: 18203133
Free Radic Res. 2006 Jun;40(6):543-52
pubmed: 16753831
Curr Radiopharm. 2008 Sep 1;1(3):177
pubmed: 20150978
Adv Sci (Weinh). 2020 Mar 17;7(9):1901519
pubmed: 32382473
Med Hypotheses. 2012 Oct;79(4):522-30
pubmed: 22874453
J Neurochem. 1999 Feb;72(2):751-6
pubmed: 9930749
Adv Sci (Weinh). 2018 Nov 27;6(2):1801479
pubmed: 30693189
Cancer Sci. 2021 Mar;112(3):1132-1140
pubmed: 33277750
Org Biomol Chem. 2018 Dec 19;17(1):165-171
pubmed: 30534678
Transl Oncol. 2019 Jul;12(7):879-888
pubmed: 31078058
Phys Med Biol. 2004 Aug 21;49(16):3703-12
pubmed: 15446799
J Cell Mol Med. 2010 Apr;14(4):840-60
pubmed: 19754673
J Clin Invest. 1997 Feb 1;99(3):424-32
pubmed: 9022075
Toxicol Sci. 2015 Feb;143(2):242-55
pubmed: 25628402
Int J Rad Appl Instrum A. 1986;37(8):799-802
pubmed: 3021681
Acc Chem Res. 2021 Aug 5;:
pubmed: 34350753
Mol Nutr Food Res. 2011 Sep;55(9):1320-31
pubmed: 21823221
Chemistry. 2016 Aug 22;22(35):12332-9
pubmed: 27305065
Chem Commun (Camb). 2021 Sep 28;57(77):9798-9806
pubmed: 34581321
Chem Soc Rev. 2005 Feb;34(2):153-63
pubmed: 15672179
Chem Sci. 2021 Apr 1;12(15):5438-5449
pubmed: 35340932
Eur J Surg Oncol. 2022 Jul;48(7):1520-1526
pubmed: 35568608
Mol Pharm. 2021 Sep 6;18(9):3553-3562
pubmed: 34403257
J Biol Chem. 1998 Jun 26;273(26):16058-66
pubmed: 9632657
Sci Rep. 2021 Jun 21;11(1):12982
pubmed: 34155314
Chem Sci. 2018 Dec 21;10(7):1936-1944
pubmed: 30881623
Bioorg Med Chem. 2007 May 15;15(10):3430-6
pubmed: 17387017

Auteurs

Yudai Ode (Y)

Department of Chemical Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology 2-12-1 Ookayama Meguro Tokyo 152-8552 Japan pradipta.a.aa@m.titech.ac.jp tanaka.k.dg@m.titech.ac.jp.

Ambara R Pradipta (AR)

Department of Chemical Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology 2-12-1 Ookayama Meguro Tokyo 152-8552 Japan pradipta.a.aa@m.titech.ac.jp tanaka.k.dg@m.titech.ac.jp.

Peni Ahmadi (P)

Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan.

Akihiro Ishiwata (A)

Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan.

Akiko Nakamura (A)

Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan.

Yasuko Egawa (Y)

Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan.

Yuriko Kusakari (Y)

Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan.

Kyohei Muguruma (K)

Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan.

Yang Wang (Y)

Nuclear Chemistry Research Team, RIKEN Nishina Center for Accelerator-Based Science 2-1 Hirosawa, Wako Saitama 351-0198 Japan.

Xiaojie Yin (X)

Nuclear Chemistry Research Team, RIKEN Nishina Center for Accelerator-Based Science 2-1 Hirosawa, Wako Saitama 351-0198 Japan.

Nozomi Sato (N)

Nuclear Chemistry Research Team, RIKEN Nishina Center for Accelerator-Based Science 2-1 Hirosawa, Wako Saitama 351-0198 Japan.

Hiromitsu Haba (H)

Nuclear Chemistry Research Team, RIKEN Nishina Center for Accelerator-Based Science 2-1 Hirosawa, Wako Saitama 351-0198 Japan.

Katsunori Tanaka (K)

Department of Chemical Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology 2-12-1 Ookayama Meguro Tokyo 152-8552 Japan pradipta.a.aa@m.titech.ac.jp tanaka.k.dg@m.titech.ac.jp.
Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan.

Classifications MeSH